Skip to main content
. 2020 Sep 28;4:2398212820957847. doi: 10.1177/2398212820957847

Figure 2.

Figure 2.

(2S,6S)-HNK and (2R,6R)-HNK inhibit the induction of LTP. (A) Representative traces of fEPSPs for (2S,6S)-HNK (upper) and (2R,6R)-HNK (lower), both at 10 µM. (B) Time-course plots of single experiments for a control (black), (2S,6S)-HNK (blue) and (2R,6R)-HNK (red) experiment. (C) Pooled data for control (n = 7), 10 µM (2S,6S)-HNK (n = 5) and 10 µM (2R,6R)-HNK (n = 4). (D) Summary histograms of the level of LTP, measured 20 min after delivery of TBS. *p < 0.05, **p < 0.01, ***p < 0.001 (one-way ANOVA with Bonferroni’s correction compared to vehicle control). (E) Concentration–response curves for inhibition of LTP by ketamine (13 slices), (2S,6S)-HNK (15 slices) and (2R,6R)-HNK (6 slices). A comparison of IC50 values showed that (2S,6S)-HNK inhibited LTP with a greater potency than (2R,6R)-HNK (p < 0.05, extra sum-of-squares F test). (F) Baseline fEPSP slope measurements prior to delivery of TBS for the different experimental conditions.